Biotricity Inc (BTCY) - Total Liabilities

Latest as of September 2025: $37.98 Million USD

Based on the latest financial reports, Biotricity Inc (BTCY) has total liabilities worth $37.98 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Biotricity Inc to track the company's year-over-year net asset growth rate.

Biotricity Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Biotricity Inc's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Biotricity Inc to measure how efficiently the company converts operating cash flow to free cash.

Biotricity Inc Competitors by Total Liabilities

The table below lists competitors of Biotricity Inc ranked by their total liabilities.

Company Country Total Liabilities
Renegade Exploration Ltd
AU:RNX
Australia AU$411.21K
NetJobs Group AB
ST:NJOB
Sweden Skr758.00K
Golden Metal Resources PLC
LSE:GMET
UK GBX1.78 Million
Primarindo Asia Infrastructure Tbk PT
JK:BIMA
Indonesia Rp258.43 Billion
Science Group plc
LSE:SAG
UK GBX60.11 Million
ASA International Group PLC
LSE:ASAI
UK GBX635.26 Million
STL Global Limited
NSE:SGL
India Rs287.89 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Biotricity Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BTCY market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.23 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.14 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 6.01 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biotricity Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biotricity Inc (2014–2025)

The table below shows the annual total liabilities of Biotricity Inc from 2014 to 2025.

Year Total Liabilities Change
2025-03-31 $35.66 Million -0.74%
2024-03-31 $35.92 Million +36.29%
2023-03-31 $26.36 Million +40.02%
2022-03-31 $18.82 Million +67.00%
2021-03-31 $11.27 Million +125.21%
2020-03-31 $5.00 Million +120.64%
2019-03-31 $2.27 Million +199.97%
2018-03-31 $756.18K -84.44%
2017-03-31 $4.86 Million +176.31%
2016-03-31 $1.76 Million +876.82%
2015-03-31 $180.00K +5.53%
2014-03-31 $170.56K --

About Biotricity Inc

NASDAQ:BTCY USA Medical Devices
Market Cap
$2.92 Million
Market Cap Rank
#29499 Global
#5941 in USA
Share Price
$0.11
Change (1 day)
+0.00%
52-Week Range
$0.10 - $0.73
All Time High
$60.30
About

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes … Read more